• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FRESENIUS MEDICAL CARE NORTH AMERICA FRESENIUS COMBISET 2008

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FRESENIUS MEDICAL CARE NORTH AMERICA FRESENIUS COMBISET 2008 Back to Search Results
Catalog Number 03-2722-9
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Low Blood Pressure/ Hypotension (1914)
Event Date 03/02/2015
Event Type  Injury  
Event Description
During review of medical records for this patient for a separate event, it was discovered that patient became hypotensive and started feeling poorly during hemodialysis on (b)(6) 2015.It was suspected that patient's vancomycin resistant enterococcus (vre) infection had started again and he was started on zosyn and zyvox.An infectious disease consult was ordered.Blood culture on (b)(6) 2015 confirmed that patient had vre in his bloodstream.The patient was changed to daptomycin.
 
Manufacturer Narrative
This report is being submitted as part of a system level review which will include an investigation of all potential fresenius products being used at the time of the event.Medical record review: medical records were received and reviewed by post market surveillance clinical staff.It was noted the patient had been admitted into the hospital on (b)(6) 2015 to rule out pulmonary embolism.The contrast dye caused contrast-induced nephropathy that led to renal failure and eventually hemodialysis.During his hospitalization, the patient also developed vre sepsis.The patient's vre never resolved and the patient started having episodes of hypotension during hemodialysis on (b)(6) 2015.During this episode, the patient was unable to complete treatment due to his inability to maintain a systolic blood pressure of 90 even with the administration of dopamine drip.There are no bicarbonate levels in the medical record for review.The medical records do not show a causal relationship between the 2008k or the concomitant products used in the patient's hemodialysis treatment and the patient's hypotension.Medical records do show that the patient's unresolved infection was a possible contributor to the hypotensive episodes during his hemodialysis treatment.A supplemental report will be submitted upon completion of the plant's investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FRESENIUS COMBISET 2008
Manufacturer (Section D)
FRESENIUS MEDICAL CARE NORTH AMERICA
reynosa
MX 
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
parque industrial reynosa
reynosa, tamaulipas CP 8 8780
MX   CP 88780
Manufacturer Contact
tanya taft, rn, cnor
920 winter street
waltham, MA 02451-1457
7816999000
MDR Report Key4764610
MDR Text Key17630792
Report Number8030665-2015-00234
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility
Reporter Occupation Biomedical Engineer
Type of Report Initial
Report Date 04/09/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number03-2722-9
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/09/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
NATURALYTE BICARBONATE; NATURALYTE; 2008K HEMODIALYSIS SYSTEM; OPTIFLUX DIALYZER
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age60 YR
Patient Weight59
-
-